Warning: The NCBI web site requires JavaScript to function. more...
Year in review 2008: Critical Care--metabolism.
Preiser JC.
Crit Care. 2009;13(5):228. Epub 2009 Oct 21. Review.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Year in review 2009: Critical Care--metabolism.
Huberlant V, Preiser JC.
Crit Care. 2010;14(6):238. Epub 2010 Nov 5. Review.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature.
Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ.
Crit Care. 2006 Feb;10(1):R19. Review.
Blood glucose control in critical care patients - a review of the literature.
Parsons P, Watkinson P.
Nurs Crit Care. 2007 Jul-Aug;12(4):202-10. Review.
[Fructose vs. glucose in total parenteral nutrition in critically ill patients].
Adolph M, Eckart A, Eckart J.
Anaesthesist. 1995 Nov;44(11):770-81. German.
Causes and consequences of hyperglycemia in critical illness.
Falciglia M.
Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):498-503. Review.
Intensive care unit-acquired weakness: risk factors and prevention.
de Jonghe B, Lacherade JC, Sharshar T, Outin H.
Crit Care Med. 2009 Oct;37(10 Suppl):S309-15. Review.
Glucose control after severe brain injury.
Oddo M, Schmidt JM, Mayer SA, Chioléro RL.
Curr Opin Clin Nutr Metab Care. 2008 Mar;11(2):134-9. Review.
Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.
Horm Metab Res. 2004 Jan;36(1):54-61.
Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.
Robinson LE, van Soeren MH.
AACN Clin Issues. 2004 Jan-Mar;15(1):45-62. Review.
Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, Stevens T, Bellantoni MF, Rogers MA, Baumann G, Roth J, Harman SM, Spencer RG.
Metabolism. 1997 Jan;46(1):89-96.
A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset.
Eslami S, de Keizer NF, de Jonge E, Schultz MJ, Abu-Hanna A.
Crit Care. 2008;12(6):R139. Epub 2008 Nov 11. Review.
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL, Figgitt DP.
Pharmacoeconomics. 2004;22(6):389-411. Review.
Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients.
Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P; Canadian Critical Care Clinical Practice Guidelines Committee.
JPEN J Parenter Enteral Nutr. 2003 Sep-Oct;27(5):355-73.
Glucose control in the intensive care unit.
Fahy BG, Sheehy AM, Coursin DB.
Crit Care Med. 2009 May;37(5):1769-76. Review.
[Endocrine regulation in critically ill patients].
Wrede CE.
Dtsch Med Wochenschr. 2010 Apr;135(14):712-5. Epub 2010 Mar 31. Review. German.
Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients.
Ross RJ, Miell JP, Holly JM, Maheshwari H, Norman M, Abdulla AF, Buchanan CR.
Clin Endocrinol (Oxf). 1991 Oct;35(4):361-7.
Insulin therapy in critically ill patients.
Solano T, Totaro R.
Curr Opin Clin Nutr Metab Care. 2004 Mar;7(2):199-205. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on